Cargando…
Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse
Therapeutic vaccines have promise as adjunctive treatment for tuberculosis (TB) or as preventives against TB relapse. An important development challenge is the limited understanding of T helper (Th) cell roles during these stages of disease. A murine model of TB relapse was used to identify changes...
Autores principales: | Martinez-Martinez, Yazmin B., Huante, Matthew B., Chauhan, Sadhana, Naqvi, Kubra F., Bharaj, Preeti, Endsley, Janice J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613213/ https://www.ncbi.nlm.nih.gov/pubmed/37898618 http://dx.doi.org/10.1038/s41541-023-00761-4 |
Ejemplares similares
-
Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection
por: Huante, Matthew B., et al.
Publicado: (2020) -
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse
por: Endsley, Janice J., et al.
Publicado: (2021) -
Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?
por: Naqvi, Kubra F., et al.
Publicado: (2020) -
Antigen-specific antibody and polyfunctional T cells generated by respiratory immunization with protective BurkholderiaΔtonBΔhcp1 live attenuated vaccines
por: Khakhum, Nittaya, et al.
Publicado: (2021) -
Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Chesson, Charles B., et al.
Publicado: (2018)